Sheaff Brock Investment Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,667	Closed	-$15K	–	529
2020 Q4	$15K	Hold	21,667	–	–	﹤0.01%	481
2020 Q3	$49K	Hold	21,667	–	–	﹤0.01%	449
2020 Q2	$78K	Hold	21,667	–	–	0.01%	432
2020 Q1	$82K	Hold	21,667	–	–	0.01%	382
2019 Q4	$65K	Buy	+21,667	New	+$56.3K	0.01%	460

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Sheaff Brock Investment Advisors's BMY.RT Position: Q1 2021 in Review

Sheaff Brock Investment Advisors sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 21,667 shares — an estimated $15K sold.

Sheaff Brock Investment Advisors first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $82K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Sheaff Brock Investment Advisors reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Sheaff Brock Investment Advisors sold 21,667 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $15K.
Sheaff Brock Investment Advisors first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Sheaff Brock Investment Advisors's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $82K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2021, filed 11 May 2021.